Angiosarcoma arising in association with an arteriovenous graft (AVG) or fistula is a unique clinicopathologic scenario that appears to be gaining recognition in the literature. Among reported cases, none has described high-level MYC gene amplification, a genetic aberration that is increasingly unifying the various clinicopathologic subdivisions of angiosarcoma. We therefore report the MYC gene status in a case of angiosarcoma arising at an AVG site
Sporadic angiosarcomas are aggressive vascular sarcomas whose rarity and genomic complexity present ...
Angiosarcoma is a rare, devastating malignancy with few curative options for disseminated disease. W...
BACKGROUND: The p53 and phosphoinositide-3-kinase, catalytic, alpha polypeptide/v-akt murine thymoma...
Copyright © 2015 Kristen M. Paral et al.This is an open access article distributed under theCreative...
Angiosarcomas (ASs) represent a heterogeneous group of malignant vascular tumors that may occur spon...
Angiosarcoma (AS) is a distinct group of sarcomas characterized by upregulation of vascular-specific...
MYC amplification has been reported as a prominent feature of secondary angiosarcomas (SAS). The dif...
MYC amplification has been reported as a prominent feature of secondary angiosarcomas (SAS). The dif...
Angiosarcomas are very aggressive, rare malignant tumors that originate from vascular or lymphatic v...
Angiosarcomas (ASs) represent a heterogeneous group of malignant vascular tumors that may occur spon...
Background: Angiosarcomas may develop as primary tumours of unknown cause or as secondary tumours, m...
Primary angiosarcoma of the breast is a rare but aggressive disease with a poor 5-year survival. An ...
International audienceWe report a rare case of vascular graft-associated aneurysmal angiosarcoma by ...
Background:Angiosarcomas may develop as primary tumours of unknown cause or as secondary tumours, mo...
Vascular proliferations may arise in the breast following radiation treatment for a primary breast a...
Sporadic angiosarcomas are aggressive vascular sarcomas whose rarity and genomic complexity present ...
Angiosarcoma is a rare, devastating malignancy with few curative options for disseminated disease. W...
BACKGROUND: The p53 and phosphoinositide-3-kinase, catalytic, alpha polypeptide/v-akt murine thymoma...
Copyright © 2015 Kristen M. Paral et al.This is an open access article distributed under theCreative...
Angiosarcomas (ASs) represent a heterogeneous group of malignant vascular tumors that may occur spon...
Angiosarcoma (AS) is a distinct group of sarcomas characterized by upregulation of vascular-specific...
MYC amplification has been reported as a prominent feature of secondary angiosarcomas (SAS). The dif...
MYC amplification has been reported as a prominent feature of secondary angiosarcomas (SAS). The dif...
Angiosarcomas are very aggressive, rare malignant tumors that originate from vascular or lymphatic v...
Angiosarcomas (ASs) represent a heterogeneous group of malignant vascular tumors that may occur spon...
Background: Angiosarcomas may develop as primary tumours of unknown cause or as secondary tumours, m...
Primary angiosarcoma of the breast is a rare but aggressive disease with a poor 5-year survival. An ...
International audienceWe report a rare case of vascular graft-associated aneurysmal angiosarcoma by ...
Background:Angiosarcomas may develop as primary tumours of unknown cause or as secondary tumours, mo...
Vascular proliferations may arise in the breast following radiation treatment for a primary breast a...
Sporadic angiosarcomas are aggressive vascular sarcomas whose rarity and genomic complexity present ...
Angiosarcoma is a rare, devastating malignancy with few curative options for disseminated disease. W...
BACKGROUND: The p53 and phosphoinositide-3-kinase, catalytic, alpha polypeptide/v-akt murine thymoma...